Advanced Biomed Inc. Common Stock Capital Reinvestment Ratio

Latest as of December 2023: 1.39x

Advanced Biomed Inc. Common Stock capital reinvestment ratio. Advanced Biomed Inc. Common Stock (ADVB) has a Capital Reinvestment Ratio of 1.39x as of December 2023, meaning it reinvests 1% of its operating cash flow ($34.28K) in capital expenditures ($47.55K). See Advanced Biomed Inc. Common Stock (ADVB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.39x

Capex / Operating Cash Flow

Operating Cash Flow

$34.28K

USD

Capital Expenditures

$47.55K

USD

Data as of

Dec 2023

Most recent filing

Advanced Biomed Inc. Common Stock Capital Reinvestment Ratio by Year (None–None)

Advanced Biomed Inc. Common Stock capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see ADVB operating cash flow.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow